About Kezzler
Kezzler is a company based in Oslo (Norway) founded in 2001. Kezzler has raised $6.73 million across 2 funding rounds from investors including DNV, BillerudKorsnas and Investinor. Kezzler offers products and services including Kezzler Platform and Digital Product Passport. Kezzler operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, TrusTrace and Recipharm, among others.
- Headquarter Oslo, Norway
-
Sectors
RetailHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kezzler Hindustan Private Limited
- Date of Incorporation 19 Feb, 2016
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$216.63 K (USD)5.14as on Mar 31, 2023
-
Net Profit
$27.24 K (USD)66.63as on Mar 31, 2023
-
EBITDA
-$84.21 K (USD)1.76as on Mar 31, 2023
-
Total Equity Funding
$6.73 M (USD)
in 2 rounds
-
Latest Funding Round
$6.73 M (USD), Series A
Nov 03, 2021
-
Investors
DNV
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kezzler
Kezzler offers a comprehensive portfolio of products and services, including Kezzler Platform and Digital Product Passport.
Software for managing product data and ensuring regulatory compliance.
Solution for tracking product lifecycle and meeting EU regulations.
Funding Insights of Kezzler
Kezzler has successfully raised a total of $6.73M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.73 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $6.7M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series A - Kezzler | Valuation | Investinor , DNV |
|
| Oct, 2016 | Amount | Private Equity Round - Kezzler | Valuation | BillerudKorsnas |
|
Investors in Kezzler
Kezzler has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include DNV, BillerudKorsnas and Investinor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Offshore classification, training, advisory, and analytics services are provided.
|
Founded Year | Domain | Location | |
|
Watrium is engaged in long-term investment and active ownership.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kezzler
Financial Statements - Kezzler
Kezzler Comparisons
Competitors of Kezzler
Kezzler operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, TrusTrace and Recipharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Blockchain-based traceability and sustainability solutions for the fashion industry
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
Frequently Asked Questions about Kezzler
Kezzler was founded in 2001 and raised its 1st funding round 15 years after it was founded.
Kezzler is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Kezzler is a funded company, having raised a total of $6.73M across 2 funding rounds to date.
Annual revenue of Kezzler is $216.63K as on Mar 31, 2023.
Kezzler claims to be a pioneer in mass serialization services for the food, FMCG, pharmaceutical and packaging industries and also for governments. Their solutions include brand protection, track trace, and consumer engagement. Their pharmaceutical offering is a secure and scalable technology that can be easily implemented into the standardized GS1 2D barcodes (a type of 2D barcode which can hold a significant amount of information and may remain legible even when printed at a small size or etched onto a product). Kezzler had signed an agreement with SGS (a leader in inspection, verification, testing and certification) in May 2017, for the use of its technology to track and monitor SGSs supply chains, to reduce inefficiencies, manage product recalls and exchange real time info. with customers.
Kezzler's top competitors include TrusTrace, Jubilant Life Sciences and Akums.
Kezzler offers Kezzler Platform and Digital Product Passport.
Kezzler has 5 investors. Key investors include DNV, BillerudKorsnas, Investinor, Watrium, and Vestland Group.